Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager

Sartorius Stedim Biotech SA

PAR:DIM

Watchlist

Price: 179.65 EUR -1.02% Market Closed

Market Cap: 17.5B EUR

Have any thoughts about
Sartorius Stedim Biotech SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 179.65 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DIM Alert

Sartorius Stedim Biotech SA

179.65

-1.85 (-1.02%)

52 Week Range	145.35 280
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Sartorius Stedim Biotech SA

What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?

What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Sartorius Stedim Biotech SA.

What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?

What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?

Summarize the latest earnings call
of Sartorius Stedim Biotech SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sartorius Stedim Biotech SA.

Provide P/S
for Sartorius Stedim Biotech SA.

Provide P/E
for Sartorius Stedim Biotech SA.

Provide P/OCF
for Sartorius Stedim Biotech SA.

Provide P/FCFE
for Sartorius Stedim Biotech SA.

Provide P/B
for Sartorius Stedim Biotech SA.

Provide EV/S
for Sartorius Stedim Biotech SA.

Provide EV/GP
for Sartorius Stedim Biotech SA.

Provide EV/EBITDA
for Sartorius Stedim Biotech SA.

Provide EV/EBIT
for Sartorius Stedim Biotech SA.

Provide EV/OCF
for Sartorius Stedim Biotech SA.

Provide EV/FCFF
for Sartorius Stedim Biotech SA.

Provide EV/IC
for Sartorius Stedim Biotech SA.

Show me price targets
for Sartorius Stedim Biotech SA made by professional analysts.

What are the Revenue projections
for Sartorius Stedim Biotech SA?

How accurate were the past Revenue estimates
for Sartorius Stedim Biotech SA?

What are the Net Income projections
for Sartorius Stedim Biotech SA?

How accurate were the past Net Income estimates
for Sartorius Stedim Biotech SA?

What are the EPS projections
for Sartorius Stedim Biotech SA?

How accurate were the past EPS estimates
for Sartorius Stedim Biotech SA?

What are the EBIT projections
for Sartorius Stedim Biotech SA?

How accurate were the past EBIT estimates
for Sartorius Stedim Biotech SA?

Compare the revenue forecasts
for Sartorius Stedim Biotech SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sartorius Stedim Biotech SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sartorius Stedim Biotech SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sartorius Stedim Biotech SA compared to its peers.

Compare the P/E ratios
of Sartorius Stedim Biotech SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Sartorius Stedim Biotech SA with its peers.

Analyze the financial leverage
of Sartorius Stedim Biotech SA compared to its main competitors.

Show all profitability ratios
for Sartorius Stedim Biotech SA.

Provide ROE
for Sartorius Stedim Biotech SA.

Provide ROA
for Sartorius Stedim Biotech SA.

Provide ROIC
for Sartorius Stedim Biotech SA.

Provide ROCE
for Sartorius Stedim Biotech SA.

Provide Gross Margin
for Sartorius Stedim Biotech SA.

Provide Operating Margin
for Sartorius Stedim Biotech SA.

Provide Net Margin
for Sartorius Stedim Biotech SA.

Provide FCF Margin
for Sartorius Stedim Biotech SA.

Show all solvency ratios
for Sartorius Stedim Biotech SA.

Provide D/E Ratio
for Sartorius Stedim Biotech SA.

Provide D/A Ratio
for Sartorius Stedim Biotech SA.

Provide Interest Coverage Ratio
for Sartorius Stedim Biotech SA.

Provide Altman Z-Score Ratio
for Sartorius Stedim Biotech SA.

Provide Quick Ratio
for Sartorius Stedim Biotech SA.

Provide Current Ratio
for Sartorius Stedim Biotech SA.

Provide Cash Ratio
for Sartorius Stedim Biotech SA.

What is the historical Revenue growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the historical Net Income growth
over the last 5 years for Sartorius Stedim Biotech SA?

What is the current Free Cash Flow
of Sartorius Stedim Biotech SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sartorius Stedim Biotech SA.

DIM

Balance Sheet

Current Portion of Long-Term Debt

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt Peer Comparison

Comparables:

PCA

ALECR

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

	Current Portion of Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sartorius Stedim Biotech SA PAR:DIM	Current Portion of Long-Term Debt €152.1m	CAGR 3-Years 57%	CAGR 5-Years 11%	CAGR 10-Years 15%
Pcas SA PAR:PCA	Current Portion of Long-Term Debt €4.4m	CAGR 3-Years -16%	CAGR 5-Years -2%	CAGR 10-Years -5%
Eurofins-Cerep SA PAR:ALECR	Current Portion of Long-Term Debt €3k	CAGR 3-Years -58%	CAGR 5-Years N/A	CAGR 10-Years -45%

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
152.1m EUR

Based on the financial report for Jun 30, 2024, Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt amounts to 152.1m EUR.

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 10Y
15%

Over the last year, the Current Portion of Long-Term Debt growth was 463%. The average annual Current Portion of Long-Term Debt growth rates for Sartorius Stedim Biotech SA have been 57% over the past three years , 11% over the past five years , and 15% over the past ten years .

Sartorius Stedim Biotech SA
PAR:DIM

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

See Also

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
152.1m EUR

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 10Y
15%

Company

Help

Tools

Stocks

Sartorius Stedim Biotech SA PAR:DIM

Sartorius Stedim Biotech SA Current Portion of Long-Term Debt

Sartorius Stedim Biotech SA Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis Latest Figures & CAGR of Competitors

See Also

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt? Current Portion of Long-Term Debt 152.1m EUR

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt growth rate? Current Portion of Long-Term Debt CAGR 10Y 15%

Company

Help

Tools

Stocks

Sartorius Stedim Biotech SA
PAR:DIM

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt

Sartorius Stedim Biotech SA
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
152.1m EUR

What is Sartorius Stedim Biotech SA's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 10Y
15%